The Rundown Spotify Shares Slip on Profit Miss, Hims Partners with Novo Nordisk for Wegovy
15 snips
Apr 29, 2025 The podcast kicks off with a lively stock market update, revealing recent volatility and the S&P 500's recovery potential. It delves into Spotify's impressive subscriber growth juxtaposed with a profit miss, sparking intriguing discussions about market reactions. The conversation shifts to GM, assessing the ramifications of new auto tariffs on their future. Exciting news about the partnership between Hims and Novo Nordisk for Wegovy catches listeners' attention, along with insights into recent earnings from PayPal and Amazon.
AI Snips
Chapters
Transcript
Episode notes
Spotify's Growth vs. Profit Miss
- Spotify's subscriber growth is strong with a 12% increase in premium users to 268 million.
- However, profit miss related to higher payroll taxes linked to share appreciation disappointed investors.
GM Faces Tariff Uncertainty
- GM topped earnings but caution stems from uncertain impact of new 25% auto tariffs.
- The fluid tariff situation hinders accurate forecasting and elevated investor nervousness.
Hims Stock Surges on Novo Deal
- Hims' partnership with Novo Nordisk to offer Wegovy drives a massive stock rally.
- This reflects investor optimism on telehealth platforms distributing popular weight loss drugs.